Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System

Summary

This study is an exploratory cohort study conducted under real-world conditions, aiming to evaluate the feasibility of an artificial intelligence (AI)-guided standard treatment selection model for advanced solid tumors, as well as its superiority compared to clinician-selected treatment plans. A multi-agent system based on multimodal AI models will rank the priority of standard treatment options based on the personalized information of the patients, including including demographics, clinical information, and multi-omics data. The final treatment plan will be jointly selected by the patient and the clinician from the AI-recommended options, thereby delivering a personalized treatment.

Timeline

Start

2025-03-01

Primary completion

2028-02-29

Completion

2030-02-28

Drugs

Indications